{"component": "definition", "props": {"groups": [{"snippet": "mean licenses granted by NOBLE to third parties (\u201cSublicensees\u201d), as authorized by this Agreement.", "snippet_links": [{"key": "granted-by", "type": "definition", "offset": [14, 24]}, {"key": "to-third-parties", "type": "clause", "offset": [31, 47]}, {"key": "by-this-agreement", "type": "clause", "offset": [80, 97]}], "size": 6, "samples": [{"hash": "dMldYhXcF17", "uri": "/contracts/dMldYhXcF17#sublicenses", "label": "License Agreement (Ceres, Inc.)", "score": 22.7823408624, "published": true}, {"hash": "8Rs6IXC4S5F", "uri": "/contracts/8Rs6IXC4S5F#sublicenses", "label": "License Agreement (Ceres, Inc.)", "score": 22.7823408624, "published": true}, {"hash": "35RaPGDCjcU", "uri": "/contracts/35RaPGDCjcU#sublicenses", "label": "Evaluation, Production and License Agreement (Ceres, Inc.)", "score": 22.7823408624, "published": true}], "hash": "05d1277141a82b4e71e303ad093e8c8f", "id": 1}, {"snippet": "will mean an agreement between Licensee and any third party granting a license to the Patent Rights so the sublicensee may make, use or sell Licensed Products and/or Licensed Process(es), in whole or in part, for any term.", "snippet_links": [{"key": "agreement-between", "type": "clause", "offset": [13, 30]}, {"key": "third-party", "type": "clause", "offset": [48, 59]}, {"key": "license-to", "type": "clause", "offset": [71, 81]}, {"key": "patent-rights", "type": "definition", "offset": [86, 99]}, {"key": "the-sublicensee", "type": "clause", "offset": [103, 118]}, {"key": "licensed-products", "type": "definition", "offset": [141, 158]}], "size": 5, "samples": [{"hash": "ljWGre76wzK", "uri": "/contracts/ljWGre76wzK#sublicenses", "label": "License Agreement", "score": 30.5898448209, "published": true}, {"hash": "c544vipLltO", "uri": "/contracts/c544vipLltO#sublicenses", "label": "License Agreement", "score": 27.8008213552, "published": true}, {"hash": "jngLBiElWtT", "uri": "/contracts/jngLBiElWtT#sublicenses", "label": "License Agreement", "score": 25.8637919233, "published": true}], "hash": "ed70cd34d6d6d42be4479aaffcb1b042", "id": 2}, {"snippet": "means, collectively, (i) the license agreement dated as of June 15, 1998 between the Seller and Cruachem, Inc., which is attached hereto as Exhibit E, and (ii) the license agreement dated as of January 29, 1999 between the Seller and JBL Scientific, Inc., which is attached hereto as Exhibit F, pursuant to each of which Seller has sublicensed certain rights under the Lynx Patents and the Northwestern Patents.", "snippet_links": [{"key": "the-license-agreement", "type": "clause", "offset": [25, 46]}, {"key": "dated-as-of", "type": "definition", "offset": [47, 58]}, {"key": "the-seller", "type": "clause", "offset": [81, 91]}, {"key": "exhibit-e", "type": "definition", "offset": [140, 149]}, {"key": "exhibit-f", "type": "clause", "offset": [284, 293]}, {"key": "pursuant-to", "type": "definition", "offset": [295, 306]}, {"key": "certain-rights", "type": "clause", "offset": [344, 358]}, {"key": "lynx-patents", "type": "definition", "offset": [369, 381]}], "size": 4, "samples": [{"hash": "plVhJX771a", "uri": "/contracts/plVhJX771a#sublicenses", "label": "Purchase Agreement (Lynx Therapeutics Inc)", "score": 18.0, "published": true}, {"hash": "jFBgqZu1S7X", "uri": "/contracts/jFBgqZu1S7X#sublicenses", "label": "Purchase Agreement (Lynx Therapeutics Inc)", "score": 18.0, "published": true}, {"hash": "3bUeJVs60FJ", "uri": "https://www.sec.gov/Archives/edgar/data/886744/000089161802001754/f79765a1ex10-1.txt", "label": "Geron Corporation", "score": 2.0, "published": false}], "hash": "f2b9b18bcfcb4d0eafa65d223cbcfd1f", "id": 3}, {"snippet": "of the AAV/HLA-engineering licence;", "snippet_links": [], "size": 3, "samples": [{"hash": "cP18tFqlDnw", "uri": "/contracts/cP18tFqlDnw#sublicenses", "label": "Research Collaboration and License Agreement (Adaptimmune Therapeutics PLC)", "score": 31.1546885695, "published": true}, {"hash": "g2uA2m6tocZ", "uri": "/contracts/g2uA2m6tocZ#sublicenses", "label": "Research Collaboration and License Agreement (Adaptimmune Therapeutics PLC)", "score": 27.2067077344, "published": true}, {"hash": "eMA3XpLenPQ", "uri": "/contracts/eMA3XpLenPQ#sublicenses", "label": "Hla/Aav Sublicence (Adaptimmune Therapeutics PLC)", "score": 26.2067077344, "published": true}], "hash": "b157a9128138cb1b0c1a9813feccbae8", "id": 4}, {"snippet": "means any sublicense granted by GTx, to a Joint Alliance, Joint Alliance Party, Residual Alliance or a Residual Alliance Party.", "snippet_links": [{"key": "granted-by", "type": "definition", "offset": [21, 31]}], "size": 3, "samples": [{"hash": "mJhkpgXipU", "uri": "/contracts/mJhkpgXipU#sublicenses", "label": "Exclusive License Agreement (GTX Inc/Tn)", "score": 18.0, "published": true}, {"hash": "hL2VJREMk2L", "uri": "/contracts/hL2VJREMk2L#sublicenses", "label": "Exclusive License Agreement (GTX Inc/Tn)", "score": 18.0, "published": true}, {"hash": "3voIUxkmYLd", "uri": "/contracts/3voIUxkmYLd#sublicenses", "label": "Exclusive License Agreement (GTX Inc/Tn)", "score": 18.0, "published": true}], "hash": "dbdf156a9a0339991fbba7a36260fe7e", "id": 5}, {"snippet": "means the sublicense agreements in the forms of Exhibits H-1 and H-2 hereto.", "snippet_links": [{"key": "sublicense-agreements", "type": "definition", "offset": [10, 31]}], "size": 3, "samples": [{"hash": "7tjs8Wvrnyp", "uri": "/contracts/7tjs8Wvrnyp#sublicenses", "label": "Asset Purchase and Sale Agreement (Tellabs Inc)", "score": 21.0, "published": true}, {"hash": "4mCn4hbx0Hg", "uri": "/contracts/4mCn4hbx0Hg#sublicenses", "label": "Asset Purchase and Sale Agreement (Advanced Fibre Communications Inc)", "score": 18.0, "published": true}, {"hash": "2YffXvz3YID", "uri": "/contracts/2YffXvz3YID#sublicenses", "label": "Asset Purchase and Sale Agreement (Marconi Corp PLC)", "score": 18.0, "published": true}], "hash": "b462f9b94efd64b910ff2264c1e8f150", "id": 6}, {"snippet": "means any transaction between COMPANY and a non-Affiliate third party under which COMPANY (a) grants, transfers or agrees not to assert any of the rights licensed to COMPANY hereunder, or (b) is under an obligation to grant or transfer such rights or to forebear from granting or transferring such rights, including by means of an option.", "snippet_links": [{"key": "a-non", "type": "clause", "offset": [42, 47]}, {"key": "third-party", "type": "clause", "offset": [58, 69]}, {"key": "rights-licensed", "type": "clause", "offset": [147, 162]}, {"key": "company-hereunder", "type": "clause", "offset": [166, 183]}, {"key": "obligation-to", "type": "clause", "offset": [204, 217]}, {"key": "such-rights", "type": "definition", "offset": [236, 247]}], "size": 3, "samples": [{"hash": "idqOP65xen0", "uri": "/contracts/idqOP65xen0#sublicenses", "label": "Exclusive License Agreement (Kintara Therapeutics, Inc.)", "score": 35.3627652293, "published": true}, {"hash": "dA0Rqnleddh", "uri": "/contracts/dA0Rqnleddh#sublicenses", "label": "Exclusive License Agreement (CohBar, Inc.)", "score": 34.659137577, "published": true}, {"hash": "3XJpO6G95DW", "uri": "/contracts/3XJpO6G95DW#sublicenses", "label": "Exclusive License Agreement (CohBar, Inc.)", "score": 34.6043805613, "published": true}], "hash": "de3bb8d4e3364e1942628a1071971e96", "id": 7}, {"snippet": "University will review the unexecuted Sublicense and will, within 20 business days of receipt of the proposed Sublicense, either provide express written approval for the Sublicense as presented or decline consent for the transaction. Such approval will not be unreasonably withheld. If approval is granted, Company will provide University copies of the Sublicense agreement within 30 days of its execution. Company shall not enter into such agreement if the terms of the agreement are inconsistent in any respect with the material terms of this Agreement. Any Sublicense made in violation of this Subsection will be void and will constitute an event of default under Subsection 9.1.1 \u201cBreach by Company\u201d.", "snippet_links": [{"key": "receipt-of", "type": "clause", "offset": [86, 96]}, {"key": "the-proposed", "type": "clause", "offset": [97, 109]}, {"key": "written-approval", "type": "definition", "offset": [145, 161]}, {"key": "the-sublicense", "type": "clause", "offset": [166, 180]}, {"key": "the-transaction", "type": "clause", "offset": [217, 232]}, {"key": "will-provide", "type": "clause", "offset": [315, 327]}, {"key": "copies-of-the", "type": "clause", "offset": [339, 352]}, {"key": "sublicense-agreement", "type": "clause", "offset": [353, 373]}, {"key": "the-terms-of-the-agreement", "type": "clause", "offset": [454, 480]}, {"key": "terms-of-this-agreement", "type": "clause", "offset": [531, 554]}, {"key": "in-violation", "type": "definition", "offset": [576, 588]}, {"key": "this-subsection", "type": "definition", "offset": [592, 607]}, {"key": "event-of-default-under", "type": "definition", "offset": [644, 666]}, {"key": "breach-by-company", "type": "clause", "offset": [685, 702]}], "size": 3, "samples": [{"hash": "7EKvtm1554T", "uri": "/contracts/7EKvtm1554T#sublicenses", "label": "Exclusive Patent License Agreement (Solid Biosciences Inc.)", "score": 35.1957563313, "published": true}, {"hash": "l9N1ncBDQ4p", "uri": "/contracts/l9N1ncBDQ4p#sublicenses", "label": "Exclusive Patent License Agreement", "score": 31.340862423, "published": true}, {"hash": "gsll5HhgPnO", "uri": "/contracts/gsll5HhgPnO#sublicenses", "label": "Exclusive Patent License Agreement (Solid Biosciences, LLC)", "score": 28.5893223819, "published": true}], "hash": "47b6290b95ee33244d2c35b4d6c297e5", "id": 8}, {"snippet": "means the sublicenses executed between the Parties and in the agreed form set out in Schedules 2 and 3.", "snippet_links": [{"key": "between-the-parties", "type": "clause", "offset": [31, 50]}, {"key": "in-the-agreed-form", "type": "definition", "offset": [55, 73]}, {"key": "set-out", "type": "definition", "offset": [74, 81]}, {"key": "schedules-2", "type": "clause", "offset": [85, 96]}], "size": 3, "samples": [{"hash": "cP18tFqlDnw", "uri": "/contracts/cP18tFqlDnw#sublicenses", "label": "Research Collaboration and License Agreement (Adaptimmune Therapeutics PLC)", "score": 31.1546885695, "published": true}, {"hash": "g2uA2m6tocZ", "uri": "/contracts/g2uA2m6tocZ#sublicenses", "label": "Research Collaboration and License Agreement (Adaptimmune Therapeutics PLC)", "score": 27.2067077344, "published": true}, {"hash": "ecingGiyhD8", "uri": "https://ir.adaptimmune.com/static-files/8b0f1ace-5085-4242-a770-cdab7ffe6fae", "label": "ir.adaptimmune.com", "score": 10.1704312115, "published": false}], "hash": "224c3c1e0a75ee566652106d8f8323b1", "id": 9}, {"snippet": "means any Third Party to which Proprius or its Affiliate grants a sublicense of its license under the Licensed Technology.", "snippet_links": [{"key": "third-party", "type": "clause", "offset": [10, 21]}, {"key": "licensed-technology", "type": "definition", "offset": [102, 121]}], "size": 3, "samples": [{"hash": "hbv1zosXDcn", "uri": "/contracts/hbv1zosXDcn#sublicenses", "label": "License Agreement (Exagen Diagnostics Inc)", "score": 25.7693360712, "published": true}, {"hash": "9x1Q3v0T6yi", "uri": "/contracts/9x1Q3v0T6yi#sublicenses", "label": "License Agreement (Exagen Diagnostics Inc)", "score": 25.7145790554, "published": true}, {"hash": "9UNGItobZcF", "uri": "/contracts/9UNGItobZcF#sublicenses", "label": "License Agreement (Exagen Diagnostics Inc)", "score": 25.5886379192, "published": true}], "hash": "30b6a3f235b6bbb021fc63aae7a0f998", "id": 10}], "next_curs": "ClgSUmoVc35sYXdpbnNpZGVyY29udHJhY3RzcjQLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIUc3VibGljZW5zZXMjMDAwMDAwMGEMogECZW4YACAA", "definition": {"snippet": "mean licenses granted by NOBLE to third parties (\u201cSublicensees\u201d), as authorized by this Agreement.", "title": "Sublicenses", "size": 63, "id": "sublicenses", "examples": ["<strong>Sublicenses</strong> with any exclusivity must include diligence requirements commensurate with the diligence requirements of Appendix \u2587.", "If Licensee receives or anticipates receipt of non-cash consideration from Sales or <strong>Sublicenses</strong>, the manner in which Licensor will receive its compensation under the Agreement with respect to such non-cash consideration will be negotiated in good faith and timely agreed to by the Parties.", "Licensee will be entitled to grant <strong>Sublicenses</strong> to third parties under the license granted pursuant to Section 2.1 subject to the terms of this Section 2.3. Any such Sublicense shall be on terms and conditions in compliance with and not inconsistent with the terms of this Agreement.", "Consistent with 35 U.S.C. \u00a7200 et seq., University retains the right to require Company to grant <strong>Sublicenses</strong> to responsible applicants in the Field of Use under the Licensed Patents on terms that are reasonable under the circumstances; or, if Company fails to grant a license, to grant the license itself.", "The Sublicensee shall assign a Software Sublicense for all Supplier Software installed on the sold, transferred or leased Aircraft and shall retain all other Software <strong>Sublicenses</strong> attached to any Aircraft that the Sublicensee continues to operate.", "Adapt shall remain responsible for the performance of its Affiliates and Sublicensees that are granted <strong>Sublicenses</strong> as permitted herein, and the grant of any such Sublicense shall not relieve Adapt of its obligations under this Agreement.", "Adapt shall have the right to grant <strong>Sublicenses</strong> (through multiple tiers of Sublicensees).", "Licensee shall use best efforts to enforce all such <strong>Sublicenses</strong> against its Sublicensees, ensuring its Sublicensees\u2019 performance in accordance with the terms of this Agreement and the relevant Sublicense.", "This report will be in the form of Appendix B and will state the number, description, and aggregate Net Sales of Licensed Product during the completed calendar time period and details about any <strong>Sublicenses</strong>.", "In addition, notwithstanding anything to the contrary in this Agreement, if a third party inquires whether a license to Patent Rights is available, then The Regents may disclose the existence of this Agreement and the extent of the grant in Articles 2 (Grant) and 3 (<strong>Sublicenses</strong>) and related definitions to such third party, but will not disclose the name of the Licensee unless Licensee has already made such disclosure publicly."], "related": [["sublicense", "Sublicense", "Sublicense"], ["licenses", "Licenses", "Licenses"], ["third-party-licenses", "Third Party Licenses", "Third Party Licenses"], ["research-license", "Research License", "Research License"], ["sublicense-agreement", "Sublicense Agreement", "Sublicense Agreement"]], "related_snippets": [], "updated": "2025-07-06T21:58:41+00:00"}, "json": true, "cursor": ""}}